医学临床研究
  2025年5月15日 星期四           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2020, Vol. 37 Issue (9): 1372-1375    DOI: 10.3969/j.issn.1671-7171.2020.09.029
  论著 本期目录 | 过刊浏览 | 高级检索 |
基于疾病智能管理系统的随访管理对类风湿性关节炎患者生活质量的影响
龚佐萍1, 李洁2, 康静1, 阳莉1, 李玲1
1.四川省南充市身心医院,四川 南充 637700;
2.四川省南充市中心医院,四川 南充 637000
Effect of Follow-up Management Based on Smart System of Disease Management (SSDM) on Self-management Ability and Quality of Life in Patients with Rheumatoid Arthritis (RA)
GONG Zuo-ping, LI Jie, KANG Jing, et al
Nanchong Physical and Mental Hospital,Nanchong Sichuan,637700
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】 探讨基于疾病智力管理系统(SSDM)的随访管理对类风湿性关节炎(RA)患者自我管理能力及生活质量的影响。【方法】 选择2016年7月至2017年6月病情好转RA出院患者112例,采用随机数字表法分为观察组和对照组各56例。对照组给予常规随访管理,观察组联合应用基于疾病智能管理系统(SSDM)进行随访管理。随访6个月,比较两组患者自我管理能力、临床疗效指标、生活质量等。【结果】 干预后,两组患者良好生活习惯、自我处置药物行为、自我监控症状行为、自我心理调节行为、自我康复训练、及时处理新问题等自我管理能力评分明显高于干预前,且观察组优于对照组,差异有统计学意义(P<0.05)。干预后,观察组DAS28评分明显低于干预前,且观察组低于对照组,差异有统计学意义(P<0.05)。干预后,观察组患者生理功能、心理功能、社会功能、健康自我认识评分明显低于干预前,且观察组低于对照组,差异具有统计学意义(P<0.05)。【结论】 基于疾病智能管理系统(SSDM)的随访管理有助于促进类风湿性关节炎患者自我管理能力的养成,改善临床症状,提高生活质量。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 关节炎,类风湿疾病管理生活质量    
Abstract【Objective】 To explore the effect of follow-up management based on Smart System of Disease Management (SSDM) on self-management ability and quality of life in patients with rheumatoid arthritis (RA). 【Methods】 A total of 112 RA patients discharged from hospital from July 2016 to June 2017 were selected,and divided into treatment group and control group with 56 cases by random number table. The control group was given routine follow-up management, and the treatment group was applied for follow-up management based on Smart System of Disease Management (SSDM) . Followed up for 6 months, the self-management ability, clinical efficacy indicators, and quality of life were compared between the two groups. 【Results】 After the intervention, for the treatment group, the scores of good habits in the treatment group were (8.12±1.02) points, the self-disposal drug behavior score was (8.25±1.14) points, the self-monitoring symptom behavior score was (6.35±0.82) points, the self-psychological adjustment behavior score was (7.68±1.21) points, the self-recovery training score was (7.52±1.21) points, and the ability to deal with new problems in a timely manner score was (7.26±1.06) points. The self-management ability scores of the treatment group were significantly higher than those before the intervention and the control groups (P<0.05). After intervention, the score of disease activity score in 28joints (DAS28) in the treatment group was (2.54±0.40) points, significantly lower than those before self intervention and the control group (P<0.05). After the intervention, the physical function score of the treatment group was (13.24±1.45) points, the psychological function score was (14.35±2.12) points, the social function score was (14.65±2.20) points, and the health self-recognition score was (13.45±1.52) points. The scores of quality of life in the treatment group were significantly lower than those before the intervention and the control group (P<0.05, P<0.01). 【Conclusion】 The follow-up management based on Smart System of Disease Management (SSDM) is helpful to promote the self-management ability of patients with rheumatoid arthritis, relieve their clinical symptoms and improve the quality of life.
Key wordsArthritis, Rheumatoid    Disease Management    Quality of Life
收稿日期: 2018-08-28     
PACS:  R593.22  
引用本文:   
龚佐萍, 李洁, 康静, 阳莉, 李玲. 基于疾病智能管理系统的随访管理对类风湿性关节炎患者生活质量的影响[J]. 医学临床研究, 2020, 37(9): 1372-1375.
GONG Zuo-ping, LI Jie, KANG Jing, et al. Effect of Follow-up Management Based on Smart System of Disease Management (SSDM) on Self-management Ability and Quality of Life in Patients with Rheumatoid Arthritis (RA). JOURNAL OF CLINICAL RESEARCH, 2020, 37(9): 1372-1375.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2020.09.029     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2020/V37/I9/1372
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn